
You can purchase shares of CELYAD SA by Celyad Oncology SA (OTCEM:CLYYF) through any online brokerage.
There are no as such competitors for CELYAD SA by Celyad Oncology SA.
There is no analysis for CELYAD SA by Celyad Oncology SA to provide a consensus price target.
The stock price for CELYAD SA by Celyad Oncology SA (OTCEM: CLYYF) is $0.28 last updated August 7, 2026 at 1:29 PM EDT.
There are no upcoming dividends for CELYAD SA by Celyad Oncology SA.
CELYAD SA by Celyad Oncology SA does not have any upcoming earnings scheduled.
There is no upcoming split for CELYAD SA by Celyad Oncology SA.
CELYAD SA by Celyad Oncology SA is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of technologies for chimeric antigen receptor T-cell (CAR T) therapies. The company focuses on solid tumors and hematological malignancies. The firm has...